Discover how the three largest pharmacy benefit managers are rejecting biosimilars from their formularies, except for their own private-label drugs.

Oklahoma's attorney general has accused CVS's Caremark pharmacy benefit manager unit of under-reimbursing pharmacies for ...

As the rising cost of insulin continues to make it difficult for so many diabetic patients to receive life-saving care, ...

The lawsuit – which has been anticipated since the FTC published a damning report on the PBM sector in July – names CVS Health's Caremark, UnitedHealth Group's Optum, and Cigna's Express ...

The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.

And this year CVS’s Caremark is rolling out simplified drug ... Express Scripts ranked No. 25 on the Fortune 500 in 2018, the year Cigna acquired it. It's now part of Cigna's $153.5 billion ...

FTC stated that the 'Big 3' PBM organisations collectively generated over £5.94 billion ($7.3 billion) in revenue from 2017 to 2022.

Unions that provide health benefits to nearly a half-million workers — including many in Ohio — have filed nearly identical ...

Many pharmacies throughout the state, including Lanning in Marion and Hillsboro Hometown in Hillsboro, will be closed Feb. 5 in support of Pharmacy Benefit Managers reform. CK Pharmacy’s three ...

In the lawsuit, AG Gentner Drummond outlined 200 individual prescription claims that were reimbursed below acquisition cost ...